Influence of different dosage schedules of inhaled fluticasone propionate on peripheral blood cytokine concentrations in childhood asthma

Clinical and Experimental Allergy

Volumn 32, Issue 10, 2002, Pages 1497-1503

  Visser, M J ^a   Postma, D S ^a   Brand, P L P ^b   Arends, L R ^c   Duiverman, E J ^a   Kauffman, H F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Division of Paediatric Pulmonology   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Airways inflammation; Asthma; Children; Cytokines; Fluticasone propionate; Inhaled corticosteroids; sICAM 1; T lymphocytes

Indexed keywords

CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE PROPIONATE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5;

ARTICLE; ASTHMA; BLOOD; CELL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; EOSINOPHIL; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ADMINISTRATION, INHALATION; ADMINISTRATION, TOPICAL; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ASTHMA; BIOLOGICAL MARKERS; BLOOD PROTEINS; BRONCHIAL HYPERREACTIVITY; CELL ADHESION MOLECULES; CHILD; CYTOKINES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN E; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-5; LEUKOCYTE COUNT; MALE; RIBONUCLEASES;

EID: 0036410830     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2745.2002.01512.x     Document Type: Article

References (48)

1. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001; 344:350-62.
2. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991; 87:893-910.
3. Hoekstra MO, Hoekstra Y, De Reus D, Rutgers B, Gerritsen J, Kauffman HF. Interleukin-4, interferon-gamma and interleukin-5 in peripheral blood of children with moderate atopic asthma. Clin Exp Allergy 1997; 27:1254-60.
4. Oymar K, Bjerknes R. Differential patterns of circulating adhesion molecules in children with bronchial asthma and acute bronchiolitis. Pediatr Allergy Immunol 1998; 9:73-9.
5. El Sawy IH, Badr-El-Din OM, El Azzouni OE, Motawae HA. Soluble intercellular adhesion molecule-1 in sera of children with bronchial asthma exacerbation. Int Arch Allergy Immunol 1999; 119:126-32.
6. National Heart, Lung and Blood Institute. National Institutes of Health. International consensus report on diagnosis and treatment of asthma (NHLBI Publication, 92-3091, March 1992). Eur Respir J 1992; 5:601-641.
7. Lantero S, Sacco O, Scala C, Morelli MC, Rossi GA. Eosinophil locomotion and the release of IL-3 and IL-5 by allergen-stimulated mononuclear cells are effectively downregulated in vitro by budesonide. Clin Exp Allergy 1996; 26:656-64.
8. Bentley AM, Hamid Q, Robinson DS et al. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med 1996; 153:551-6.
9. Wang JH, Devalia JL, Sapsford RJ, Davies RJ. Effect of corticosteroids on release of RANTES and sICAM-1 from cultured human bronchial epithelial cells, induced by TNF-alpha. Eur Respir J 1997; 10:834-40.
10. Cengizlier R, Demirpolat E, Tulek N, Cakmak F. Circulating ICAM-1 levels in bronchial asthma and the effect of inhaled corticosteroids. Ann Allergy Asthma Immunol 2000; 84:539-41.
11. Hoekstra MO, Hovenga H, Gerritsen J, Kauffman HF. Eosinophils and eosinophil-derived proteins in children with moderate asthma. Eur Respir J 1996; 9:2231-5.
12. Gemou-Engesaeth V, Bush A, Kay AB, Hamid Q, Corrigan CJ. Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and 'Th2-type' cytokine mRNA expression. Pediatrics 1997; 99:695-703.
13. El Radhi AS, Hogg CL, Bungre JK, Bush A, Corrigan CJ. Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma. Arch Dis Child 2000; 83:158-62.
14. Ferguson AC, Whitelaw M, Brown H. Correlation of bronchial eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma. J Allergy Clin Immunol 1992; 90:609-13.
15. Kamps AW, Visser MJ, de Vries TW, van Aalderen WM, Postma DS, Brand PL. The feasibility of airways hyperresponsiveness as an inclusion criterion for studies on childhood asthma. Eur Respir J 2001; 17:887-91.
16. Birnie D, thoe Schwartzenberg GW, Hop WC, van Essen-Zandvliet EE, Kerrebijn KF. Does the outcome of the tidal breathing and dosimeter methods of assessing bronchial responsiveness in children with asthma depend on age? Thorax 1990; 45:199-202.
17. Rosier MJ, Bishop J, Nolan T, Robertson CF, Carlin JB, Phelan PD. Measurement of functional severity of asthma in children. Am J Respir Crit Care Med 1994; 149:1434-41.
18. Borger P, Vellenga E, Gringhuis SI et al. Prostaglandin E2 differentially modulates IL-5 gene expression in activated human T lymphocytes depending on the costimulatory signal. J Allergy Clin Immunol 1998; 101:231-40.
19. McKenzie S. Cough-but is it asthma? Arch Dis Child 1994; 70:1-2.
20. Juntunen-Backman K, Jarvinen P, Sorva R. Serum eosinophil cationic protein during treatment of asthma in children. J Allergy Clin Immunol 1993; 92:34-8.
21. Hofstra WB, Neijens HJ, Duiverman EJ et al. Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol 2000; 29:415-23.
22. Wilson NM, James A, Uasuf C et al. Asthma severity and inflammation markers in children. Pediatr Allergy Immunol 2001; 12:125-32.
23. Imai C, Yamazaki H, Tanaka Y, Matsunaga M, Numata O, Torigoe K. Ratio of eosinophil cationic protein/eosinophil count as a new marker in children with acute asthma. Pediatr Int 1999; 41:142-6.
24. Inman MD, Denburg JA, Ellis R, Dahlback M, O'Byrne PM. The effect of treatment with budesonide or PGE2 in vitro on allergen-induced increases in canine bone marrow progenitors. Am J Respir Cell Mol Biol 1997; 17:634-41.
25. Woolley MJ, Denburg JA, Ellis R, Dahlback M, O'Byrne PM. Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters. Am J Respir Cell Mol Biol 1994; 11:600-6.
26. Meijer RJ, Kerstjens HA, Arends LR, Kauffman HF, Koeter GH, Postma DS. Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax 1999; 54:894-9.
27. Tang ML, Coleman J, Kemp AS. Interleukin-4 and interferon-gamma production in atopic and non-atopic children with asthma. Clin Exp Allergy 1995; 25:515-21.
28. Krug N, Jung T, Napp U et al. Frequencies of T cells expressing interleukin-4 and interleukin-5 in atopic asthmatic children. Comparison with atopic asthmatic adults. Am J Respir Crit Care Med 1998; 158:754-9.
29. Tang M, Kemp A, Varigos G. IL-4 and interferon-gamma production in children with atopic disease. Clin Exp Immunol 1993; 92:120-4.
30. Robinson D, Hamid Q, Ying S et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. Am Rev Respir Dis 1993; 148:401-6.
31. Visser MJ, Duiverman EJ, Postma DS, Arends LR, Brand PLP. High doses of inhaled fluticasone propionate dose-dependently suppress adrenal corticol function in asthmatic children. Eur Respir J 2001; 18:290s.
32. Tang RB, Chen SJ. Soluble interleukin-2 receptor and interleukin-4 in sera of asthmatic children before and after a prednisolone course. Ann Allergy Asthma Immunol 2001; 86:314-7.
33. Kenyon NJ, Kelly EA, Jarjour NN. Enhanced cytokine generation by peripheral blood mononuclear cells in allergic and asthma subjects. Ann Allergy Asthma Immunol 2000; 85:115-20.
34. Koning H, Neijens HJ, Baert MR, Oranje AP, Savelkoul HF. T cells subsets and cytokines in allergic and non-allergic children. II. Analysis of IL-5 and IL-10 mRNA expression and protein production. Cytokine 1997; 9:427-36.
35. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170:2081-95.
36. Moore KW, O'Garra A, de Waal MR, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11:165-90.
37. John M, Lim S, Seybold J et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1 alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med 1998; 157:256-62.
38. Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996; 97:1288-96.
39. Visser MJ, Kamps AWA, de Vries TW et al. Different immunological profiles between asthmatic children with and without airways hyperresponsiveness after withdrawal of inhaled corticosteroids. Eur Respir J 2000; 16:197s.
40. Tang C, Rolland JM, Ward C, Quan B, Walters EH. IL-5 production by bronchoalveolar lavage and peripheral blood mononuclear cells in asthma and atopy. Eur Respir J 1997; 10:624-32.
41. Lilic D, Cant AJ, Abinun M, Calvert JE, Spickett GP. Cytokine production differs in children and adults. Pediatr Res 1997; 42:237-40.
42. Elsasser-Beile U, Dursunoglu B, Gallati H, Monting JS, von Kleist S. Comparison of cytokine production in blood cell cultures of healthy children and adults. Pediatr Allergy Immunol 1995; 6:170-4.
43. Bousquet J, Ben Joseph R, Messonnier M, Alemao E, Gould AL. A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma. Clin Ther 2002; 24:1-20.
44. Verberne AA, Frost C, Duiverman EJ, Grol MH, Kerrebijn KF. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. Am J Respir Crit Care Med 1998; 158:213-9.
45. Pedersen S, Hansen OR. Budesonide treatment of moderate and severe asthma in children: A dose-response study. J Allergy Clin Immunol 1995; 95:29-33.
46. Shapiro G, Mendelson L, Kraemer MJ, Cruz-Rivera M, Walton-Bowen K, Smith JA. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma. J Allergy Clin Immunol 1998; 102:789-96.
47. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999; 159:1043-51.
48. van der Molen T, Meyboom-de Jong B, Mulder HH, Postma DS. Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment. Am J Respir Crit Care Med 1998; 158:121-5.